Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
23,008,936
-
Share change
-
+1,311,064
-
Total reported value
-
$1,446,322,852
-
Put/Call ratio
-
196%
-
Price per share
-
$62.86
-
Number of holders
-
154
-
Value change
-
+$109,382,347
-
Number of buys
-
98
-
Number of sells
-
60
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2019
As of 31 Dec 2019,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
154 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,008,936 shares.
The largest 10 holders included
FMR LLC, CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Antipodean Advisors LLC, 683 Capital Management, LLC, Grantham, Mayo, Van Otterloo & Co. LLC, JENNISON ASSOCIATES LLC, and TIGER GLOBAL MANAGEMENT LLC.
This page lists
154
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.